Showing 3 results for:
Pharmaceutical Supply Chain
Popular topics
All results
Lack of accessibility to essentials for everyday living is often the story behind the downfall of systems around the globe. For instance, Nigeria is the home of some of the world’s brightest minds, but significant setbacks include its healthcare system, which impedes its citizens from seeking to live fruitful lives. However, healthcare should be a human right, and this is what pushed DrugStoc co-founders Chibuzo Opara and Adham Yehia to create what is now Africa’s leading health tech platform. Their platform serves as a tech-enabled solution that combats the continent’s broken pharmaceutical supply chains through connecting drug store companies with hospitals and pharmacies in Nigeria. Before launching DrugStoc, Opara and Yehia founded Integra Health, a hospital management company, which paved the way for their discovery of how tech could break barriers within the pharmaceutical market. “It was quite a black box what tech could do,” Yehia told AfroTech. “We came from the health...
The African continent has experienced severe challenges in its pharmaceutical supply chains for decades leaving many people without access to medication. TechCrunch reports, “In response, the co-founders created and piloted a tech-based platform in 2015 linking manufacturers with distributors. This plan failed to take-off as it immediately became clear that a platform alone would not suffice.” In 2017, the outlet reports, those co-founders Chibuzo Opara and Adham Yehia launched DrugStoc officially to connect drug store companies with hospitals and pharmacies in Nigeria. The new model, however, proved to be successful due to new infrastructures such as fulfillment centers and warehouses to facilitate orders, packaging, shipment of products, and customer support units. Since its inception, the e-health drug procurement platform has delivered pharmaceutical products to 100 million people and has connected 400 manufacturers to 3,200 doctors, hospitals and pharmacies. The company plans...